Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 80.33
(-2.26%)
CNY 80.33
(-2.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.46 Billion | 1.24 Billion | 1.02 Billion | 688.68 Million | 542.43 Million | 431.2 Million |
| Cost of Revenue | 332.06 Million | 265.67 Million | 225.24 Million | 185.02 Million | 145.04 Million | 119.35 Million |
| Gross Profit | 1.13 Billion | 984.18 Million | 802.66 Million | 503.65 Million | 397.38 Million | 311.84 Million |
| Operating Expenses | 858.98 Million | 737.16 Million | 552.66 Million | 387.67 Million | 350.46 Million | 294.59 Million |
| Selling, General and Administrative Expenses | 670.9 Million | 510.98 Million | 377.42 Million | 270.76 Million | 241.1 Million | 209.47 Million |
| Research and Development Expenses | 167.29 Million | 145.61 Million | 88.44 Million | 63.19 Million | 53.96 Million | 40.96 Million |
| Other Expenses | 105 Thousand | 80.56 Million | 86.79 Million | 53.71 Million | 55.38 Million | -356.54 Thousand |
| Cost and Expenses | 1.19 Billion | 1 Billion | 777.91 Million | 572.7 Million | 495.51 Million | 413.95 Million |
| Operating Income | 276.51 Million | 250.1 Million | 248.39 Million | 105.73 Million | 37.68 Million | 11.52 Million |
| Interest Expense | 1.88 Million | 937.46 Thousand | 5.99 Million | 5.93 Million | 4.45 Million | 3.07 Million |
| Income Tax Expense | 24.95 Million | 22.03 Million | 34.43 Million | 9.08 Million | 6.3 Million | 2.15 Million |
| Earnings before Tax | 264.99 Million | 233.71 Million | 243.54 Million | 102.54 Million | 35.81 Million | 11.16 Million |
| Net Income | 240.03 Million | 211.68 Million | 194.7 Million | 87.97 Million | 35.89 Million | 13.65 Million |
| Earnings Per Share Basic | 1.93 | 1.71 | 1.58 | 0.78 | 0.32 | 0.17 |
| Earnings Per Share Diluted | 1.93 | 1.71 | 1.58 | 0.77 | 0.32 | 0.17 |
| Weighted Average Shares Outstanding | 124.37 Million | 123.97 Million | 123.33 Million | 113 Million | 112 Million | 80.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 124.37 Million | 123.97 Million | 123.33 Million | 114.04 Million | 112 Million | 80.34 Million |
| Gross Margin | 0.77 | 0.79 | 0.78 | 0.73 | 0.73 | 0.72 |
| EBIT Margin | 0.24 | 0.25 | 0.31 | 0.23 | 0.16 | 0.12 |
| Profit Margin | 0.16 | 0.17 | 0.19 | 0.13 | 0.07 | 0.03 |
| EBITDA | 357.94 Million | 315.49 Million | 323.87 Million | 157.84 Million | 84.12 Million | 50.08 Million |
| Earnings Before Tax Margin | 0.19 | 0.20 | 0.24 | 0.15 | 0.07 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 539.61 Million | 534.08 Million | 345.81 Million | 1.45 Billion | 358.85 Million | 419.39 Million |
| Cost of Revenue | 116.4 Million | 120.25 Million | 83.61 Million | 364.8 Million | 92.61 Million | 85.62 Million |
| Gross Profit | 423.2 Million | 413.83 Million | 262.2 Million | 1.08 Billion | 266.24 Million | 333.76 Million |
| Operating Expenses | 288.88 Million | 261.12 Million | 223.82 Million | 827.98 Million | 209.12 Million | 224.61 Million |
| Selling, General and Administrative Expenses | 226.74 Million | 174.88 Million | 187.52 Million | - | 160.38 Million | 223.13 Million |
| Research and Development Expenses | 60.78 Million | 40.63 Million | 38.06 Million | - | 43.19 Million | 43.84 Million |
| Other Expenses | -1.35 Million | -261.12 Million | 1.76 Million | 105 Thousand | -5.54 Million | -903.38 Thousand |
| Cost and Expenses | 405.28 Million | 381.37 Million | 307.44 Million | 1.19 Billion | 301.73 Million | 310.24 Million |
| Operating Income | 134.32 Million | 152.71 Million | 38.37 Million | 258.37 Million | 57.11 Million | 110.53 Million |
| Interest Expense | 1.8 Million | 1.65 Million | 605.37 Thousand | 1.43 Million | 621.98 Thousand | 473.21 Thousand |
| Income Tax Expense | 16.09 Million | 24.09 Million | 6.9 Million | 24.95 Million | 4.59 Million | 15.05 Million |
| Earnings before Tax | 137.53 Million | 158.66 Million | 41.65 Million | 264.99 Million | 62.3 Million | 109.62 Million |
| Net Income | 121.44 Million | 134.57 Million | 34.74 Million | 240.03 Million | 57.7 Million | 94.57 Million |
| Earnings Per Share Basic | 0.70 | 0.77 | 0.28 | - | 0.46 | 0.76 |
| Earnings Per Share Diluted | 0.70 | 0.77 | 0.28 | - | 0.46 | 0.76 |
| Weighted Average Shares Outstanding | 174.42 Million | 174.42 Million | 124.58 Million | 124.37 Million | 124.58 Million | 123.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 174.42 Million | 174.42 Million | 124.58 Million | 124.37 Million | 124.58 Million | 123.97 Million |
| Gross Margin | 0.78 | 0.77 | 0.76 | 0.75 | 0.74 | 0.80 |
| EBIT Margin | 0.26 | 0.34 | 0.11 | - | 0.23 | 0.26 |
| Profit Margin | 0.23 | 0.25 | 0.10 | 0.17 | 0.16 | 0.23 |
| EBITDA | 139.33 Million | 179.03 Million | 39.31 Million | - | 80.81 Million | 110.16 Million |
| Earnings Before Tax Margin | 0.25 | 0.29 | 0.11 | 0.18 | 0.16 | 0.26 |
SNOA
5206
MFC-PC
DSNY
RLLVF
LSRG